Quantcast
Channel: Bristol-Myers Squibb Canada - News Releases - Cardiovascular
Browsing all 2 articles
Browse latest View live

Health Canada's Approval of an Expanded Indication for Plavix® (Clopidogrel...

View Article



Onglyza® (saxagliptin) Achieves Primary Safety Endpoint, Demonstrating No...

• SAVOR provides information on cardiovascular safety for Onglyza in the wake of past questions about cardiovascular safety of type 2 diabetes treatments • SAVOR is the largest cardiovascular outcomes...

View Article
Browsing all 2 articles
Browse latest View live




Latest Images